Dendritic cells are specialized antigen-presenting cells that play a dual role in induction of
both innate and adaptive immunity as well as T cell tolerance. Dendritic cell based vaccines …

Although different types of therapeutic vaccines against established cancerous lesions in
various indications have been developed since the 1990s, their clinical benefit is still very …

Dendritic cells (DC) constitute a unique system of cells that induce, sustain and regulate
immune responses. Distributed as sentinels throughout the body, DC are poised to capture …

The fifth international meeting on “Dendritic cell vaccination and other strategies to tip the
balance of the immune system” was held in Bamberg, Germany, on July 16–18, 2007. The 3 …

Importance of the field: Dendritic cells (DC) are a clear choice for use in cancer
immunotherapy, and much research has focused on generating DC for clinical use …

Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although
it is already in use in clinical practice, the mechanisms through which it acts need …

Dendritic cell (DC)-based anticancer vaccines have yielded disappointing results in a
multitude of clinical trials. New data suggest that the clinical efficacy of DC-based vaccines …

Dendritic cell (DC)-based cancer immunotherapy has been shown to be safe and feasible.
In clinical pilot studies, DCs primed with tumor antigens have successfully been used to …

Recent progress in the approach towards immunotherapy of cancer consists in molecular
definition of tumor antigens, new tools for phenotypical and functional characterization of …

The routine methods used to treat oncological diseases have a number of drawbacks,
including non-specific action and severe side effects for patients. Furthermore, tumor …